The first stop for professional medicines advice

Specialty

267 results

Applied filters

Choosing between oral vancomycin options

18 June 2025Organisations should choose suitable formulary options for oral vancomycin and mitigate risks. Several factors affect decision making.

Choosing between fidaxomicin options

18 June 2025Organisations should choose suitable fidaxomicin formulary options and mitigate risks. Several factors affect decision making.

Preventing harm from incorrect vinca alkaloid administration

13 June 2025Vinca alkaloids can cause paralysis and death if given by the wrong route. Understand how to reduce the risk to patients.

Managing an intrathecal chemotherapy service

13 June 2025The intrathecal route is a high-risk route of administration. There are minimum requirements for providing intrathecal chemotherapy.

Understanding risks with intrathecal administration

13 June 2025The intrathecal route is a high-risk route of administration. Incorrect administration of medicines unsafe for this route can result in patient death.

Doxycycline post exposure prophylaxis (doxyPEP)

11 June 2025SPS PGD template for supply of doxycycline post exposure prophylaxis (doxyPEP) for the prevention of syphilis.

Considerations for using medicines following bariatric surgery

30 May 2025Guidance on the physiological changes after bariatric surgery that can affect the pharmacokinetics of medicines and supplements.

Choosing a prokinetic medicine for impaired gastrointestinal motility

23 May 2025Prokinetics improve gastrointestinal motility. We advise on suitable prokinetic options, including dose and safety considerations.

Preparing to use golimumab biosimilar

21 May 2025Golimumab biosimilars are expected soon. We offer general information and implementation advice.

Ziconotide: informing intrathecal risk assessment

16 May 2025Ziconotide products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration